p17/C18-ceramide–mediated mitophagy is an endogenous neuroprotective response in preclinical and clinical brain injury
Open Access
- 1 February 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 3 (2) , pgae018
Abstract
Repeat concussions (or repetitive mild traumatic brain injury [rmTBI]) are complex pathological processes consisting of a primary insult and long-term secondary complications and are also a prerequisite for chronic traumatic encephalopathy (CTE). Recent evidence implies a significant role of autophagy-mediated dysfunctional mitochondrial clearance, mitophagy, in the cascade of secondary deleterious events resulting from TBI. C18-ceramide, a bioactive sphingolipid produced in response to cell stress and damage, and its synthesizing enzyme (CerS1) are precursors to selective stress-mediated mitophagy. A transporter, p17, mediates the trafficking of CerS1, induces C18-ceramide synthesis in the mitochondrial membrane, and acts as an elimination signal in cell survival. Whether p17-mediated mitophagy occurs in the brain and plays a causal role in mitochondrial quality control in secondary disease development after rmTBI are unknown. Using a novel repetitive less-than-mild TBI (rlmTBI) injury paradigm, ablation of mitochondrial p17/C18-ceramide trafficking in p17 knockout (KO) mice results in a loss of C18-ceramide–induced mitophagy, which contributes to susceptibility and recovery from long-term secondary complications associated with rlmTBI. Using a ceramide analog with lipid-selenium conjugate drug, LCL768 restored mitophagy and reduced long-term secondary complications, improving cognitive deficits in rlmTBI-induced p17KO mice. We obtained a significant reduction of p17 expression and a considerable decrease of CerS1 and C18-ceramide levels in cortical mitochondria of CTE human brains compared with age-matched control brains. These data demonstrated that p17/C18-ceramide trafficking is an endogenous neuroprotective mitochondrial stress response following rlmTBI, thus suggesting a novel prospective strategy to interrupt the CTE consequences of concussive TBI.Keywords
Funding Information
- MUSC Specialized Center of Research Excellence
- Scholar Program (U54 DA016511)
- South Carolina Alzheimer’s Disease Research Center
- NIH (P01 CA203628, AA025379, C06 RR015455)
- SmartState Endowment in Lipidomics and Drug Discovery
- Center of Biomedical Research Excellence
- Lipidomics and Pathobiology (P30 GM103339)
This publication has 103 references indexed in Scilit:
- Chronic traumatic encephalopathy: a spectrum of neuropathological changes following repetitive brain trauma in athletes and military personnelAlzheimer's Research & Therapy, 2014
- Mitochondria in traumatic brain injury and mitochondrial‐targeted multipotential therapeutic strategiesBritish Journal of Pharmacology, 2012
- Ceramide targets autophagosomes to mitochondria and induces lethal mitophagyNature Chemical Biology, 2012
- TBI Sex Dependently Upregulates ET-1 To Impair Autoregulation, which Is Aggravated by Phenylephrine in Males but Is Abrogated in FemalesJournal of Neurotrauma, 2012
- Acute Serum Hormone Levels: Characterization and Prognosis after Severe Traumatic Brain InjuryJournal of Neurotrauma, 2011
- Novel Model of Frontal Impact Closed Head Injury in the RatJournal of Neurotrauma, 2009
- Chronic Traumatic Encephalopathy in Athletes: Progressive Tauopathy After Repetitive Head InjuryJournal of Neuropathology & Experimental Neurology, 2009
- Microtubule assembly, organization and dynamics in axons and dendritesNature Reviews Neuroscience, 2009
- Silencing of PINK1 Expression Affects Mitochondrial DNA and Oxidative Phosphorylation in DOPAMINERGIC CellsPLOS ONE, 2009
- PINK1-Associated Parkinson's Disease Is Caused by Neuronal Vulnerability to Calcium-Induced Cell DeathMolecular Cell, 2009